Orelabrutinib (ICP-022; ICP022; ICP 022) is an oral, potent and irreversible Bruton's tyrosine kinase (BTK) inhibitor for the treatment of cancer such as B-cell lymphomas and autoimmune indications.

纯度：≥98%

CAS：1655504-04-3